AC
Acarix AB (publ)
ACIXF · OTC
$0.03 +0.00% (+$0.00)
1M +13.14%
Market Cap 291.1M kr
P/E Ratio -
Div. Yield -
ROE 100.11%
Bulios Fair Price
$0.02
23.1% downside
Current Price
$0.026
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ACIXF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
8 /100
Expensive P/B 6.71x
P/S 31.68x
EV/EBITDA N/A
Growth
46 /100
Stable Book val. growth 9.77%
Rev. growth 8.04%
FCF growth N/A
Profitability
20 /100
Weak Net margin 427.01%
Op. margin 421.83%
FCF margin 252.35%
Quality
2 /100
Poor ROE 100.11%
ROA 82.91%
Asset turnover 0.19x
Debt
69 /100
Low Current ratio 10.67x
Int. coverage -23.35x
Debt/Equity 0.00x
Stability
71 /100
Stable Rev. volatility 9.56%
EPS volatility 3.71%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ACIXF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Aamir Mahmood
Employees
8
Headquarters
Malmö
Upcoming events
05 NOV
Earnings
Upcoming earnings report